CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 86 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02794207
NCT02794207N/ACompleted

Home or Away From Home: Patient-Centered Outcomes Related to the Management of Neutropenia Which Are Most Important to Children With AML and Their Caregivers

Children's Hospital of Philadelphia·observational·Posted Jun 9, 2016·Updated Jan 27, 2020

In Brief

An observational study for Pediatric Acute Myeloid Leukemia. Completed, enrolled 86 participants across 11 sites.

Detailed Summary

The primary objectives of this study are to identify what outcomes related to the management of neutropenia are most important to children with AML and their caregivers. Patients who have completed treatment for AML and their caregivers will be interviewed in order to better understand the impact of neutropenia management on children with AML and their families. The primary outcome of these interviews is to identify patient-centered outcomes related to neutropenia management to include in a subsequent comparative-effectiveness analysis. Investigators will use these data to develop a structured survey for administration to prospectively identified patients in subsequent studies.

Study Details

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJun 9, 2016
Enrollment StartAug 1, 2015
Primary CompletionJan 3, 2017
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 10.1 years ago